Newswise — Ahead of World Malaria Day on Friday, April 25, the director of the at the Johns Hopkins Bloomberg School of Public Health is available for interviews to discuss the impact of funding cuts on malaria research and control, the latest in malaria R&D, and the importance of continued and sustained funding against the global threat.
The facts:
- According to the World Health Organization, progress in fighting malaria isdue to cuts in international funding. Since 2000, increased investments have helped avert over 2 billion malaria cases and 12 million deaths. However, recent reductions in foreign aid jeopardize these hard-won gains and threaten the future of promising interventions such as new malaria vaccines and next-generation vector-control tools.
- Nearly 600,000 people died from malaria, with children under 5 in the accounting for the vast majority of deaths, according to WHO.
- Despite malaria being eliminated in the U.S., locally transmitted cases were reported for the first time in 20 years in 2023, underscoring the importance of global surveillance, domestic vigilance, and sustained funding.
- from the Johns Hopkins Malaria Research Institute is uncovering mosquito molecular mechanisms that could lead to breakthrough approaches in stopping transmission.
The expert:
- , PhD, is director of the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health and a Bloomberg Distinguished Professor of Malaria Genomics and Global Public Health. She specializes in using genomics to better understand the biology and evolution of malaria parasites and their mosquito vectors.
Professor Carlton can speak to:
- The consequences of reduced funding for malaria research and control.
- The promise and challenges of malaria R&D.
- Innovative strategies in mosquito vector control and genetic modification.
- How global and domestic trends intersect in the fight against malaria.
To schedule an interview, please contact: Abubakr Uqdah: [email protected]
Resources:
RSS